Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Oct 25, 2021 10:49pm
160 Views
Post# 34048109

RE:Year End was July 31

RE:Year End was July 31If history repeats itself the Annual Financials will not be out until the end of November. I doubt there will be much in the way of revenue as nothing happened in Q4 that would have added to revenues.

What might very well be informative is the MD&A that goes along with the release. Often these give some insight not only to a calendar of the years (2021 company year) highlights but also some indication of what the immediate to midterm future might hold. Surely FDA EUA will have taken place by then which could lead to the release of some positive forecasts ....particularly for Q2 of 2022 (November, December, January).

This MD&A might also give some insight as to what stage the Venowave contract is at.

Cheers!

dmshediac wrote: we should be getting something soon, end of week?? Would be nice to see: "Revenues"


<< Previous
Bullboard Posts
Next >>